BioSpace

Pfizer ‘Confident’ in Valneva-Partnered Lyme Vaccine Despite Missed Primary Endpoint

The multivalent candidate, being developed by Pfizer and French partner Valneva under a 2020 pact, generated higher than 73% ...
STAT

Pfizer’s Lyme vaccine results set up tricky regulatory path

New results on Pfizer's Lyme disease vaccine, how the Middle East conflict could strain drug supply chains, and more biotech ...

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

By Padmanabhan Ananthan March 9 (Reuters) - U.S. drugmaker Pfizer said on Monday its experimental drug for a chronic skin disease met the main goal in a mid-stage study. Here are some details: * The ...
Texarkana Gazette

Pfizer to make generic Viagra pill available beginning Monday

TRENTON, N.J.-The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales ...

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

March 17 () - Pfizer said on Tuesday its experimental combination reduced the risk of disease progression ‌or death by 40% in ...

Should You Avoid Pfizer? Here's the Key Risk to Watch

Pfizer has reached a turning point.

Pfizer’s oral CDK4 inhibitor shows promise in second-line breast cancer

Pfizer’s CDK4 inhibitor, atirmociclib, is already being investigated in a Phase III trial as a first-line therapy.